Investigating the role of long non-coding RNAs in ER+ breast cancer
Long non-coding RNA Heterogeneity in ER + Breast Cancer
This study is looking at special molecules in breast cancer that has estrogen receptors to see how they might affect the way the cancer grows and responds to treatment, with the hope of finding better, more personalized treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10884218 on NIH RePORTER |
What this research studies
This research focuses on understanding the diversity of long non-coding RNAs (lncRNAs) in estrogen receptor-positive (ER+) breast cancer. By examining the structure and function of specific lncRNAs, the study aims to uncover their roles in cancer progression and treatment response. Patients may benefit from insights that could lead to more personalized and effective treatment strategies based on the unique lncRNA profiles of their tumors. The research employs advanced molecular biology techniques to analyze tumor samples and identify potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with estrogen receptor-positive breast cancer.
Not a fit: Patients with other types of breast cancer or those who do not have breast cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more tailored treatment options for patients with ER+ breast cancer, improving outcomes and quality of life.
How similar studies have performed: Previous research has shown promising results in targeting lncRNAs for cancer treatment, indicating potential for success in this area.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Przanowska, Roza Kamila — University of Virginia
- Study coordinator: Przanowska, Roza Kamila
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.